Franklin Resources
TSHA icon

Franklin Resources’s Taysha Gene Therapies TSHA Stock Holding History

Franklin Resources’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$724K Sell
106,290
-2,109
-2% -$12.5K ﹤0.01% 2422
2026
Q1 		$485K Hold
108,399
– – ﹤0.01% 2471
2025
Q4 		$596K Hold
108,399
– – ﹤0.01% 2325
2025
Q3 		$354K Hold
108,399
– – ﹤0.01% 2589
2025
Q2 		$250K Sell
108,399
-7,839
-7% -$17K ﹤0.01% 2642
2025
Q1 		$162K Buy
+116,238
New +$194K ﹤0.01% 2740
2024
Q4 		– Sell
-100,795
Closed -$201K – 3027
2024
Q3 		$201K Buy
+100,795
New +$221K ﹤0.01% 2637
2023
Q4 		– Sell
-810,840
Closed -$2.56M – 2723
2023
Q3 		$2.56M Hold
810,840
– – ﹤0.01% 1303
2023
Q2 		$536K Hold
810,840
– – ﹤0.01% 1940
2023
Q1 		$647K Sell
810,840
-229
-0% -$296 ﹤0.01% 1615
2022
Q4 		$1.83M Hold
811,069
– – ﹤0.01% 1388
2022
Q3 		$1.56M Hold
811,069
– – ﹤0.01% 1417
2022
Q2 		$3.02M Sell
811,069
-489,599
-38% -$1.94M ﹤0.01% 1244
2022
Q1 		$8.48M Sell
1,300,668
-7,865
-0.6% -$58.8K ﹤0.01% 1055
2021
Q4 		$15.2M Sell
1,308,533
-1,677
-0.1% -$25.3K 0.01% 959
2021
Q3 		$24.4M Buy
1,310,210
+4,364
+0.3% +$83K 0.01% 847
2021
Q2 		$27.7M Buy
1,305,846
+186,677
+17% +$4.3M 0.01% 792
2021
Q1 		$22.7M Buy
1,119,169
+319,640
+40% +$8.65M 0.01% 809
2020
Q4 		$21.2M Sell
799,529
-991
-0.1% -$21.3K 0.01% 804
2020
Q3 		$17.9M Buy
+800,520
New +$18.8M 0.01% 798

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources's TSHA Position: Q2 2026 in Review

Franklin Resources reduced its Taysha Gene Therapies (TSHA) stake by 1.9% in Q2 2026, selling an estimated $12.5K and leaving 106,290 shares worth $724K. The position accounts for ﹤0.01% of the portfolio, ranked #2422.

Franklin Resources first reported a position in TSHA in Q3 2020 and has held it in 20 quarters since. The position peaked at $27.7M in Q2 2021. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Franklin Resources held 106,290 shares of Taysha Gene Therapies worth $724K as of Q2 2026.
  • Franklin Resources sold 2,109 Taysha Gene Therapies shares in Q2 2026, an estimated $12.5K.
  • Taysha Gene Therapies made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2422 holding.
  • Franklin Resources first reported a position in Taysha Gene Therapies in Q3 2020 and has held it in 20 quarters since.
  • Franklin Resources's Taysha Gene Therapies position peaked at $27.7M in Q2 2021.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.